Differences between revisions 1 and 2
Revision 1 as of 2006-11-15 16:00:26
Size: 2860
Editor: lfrq80
Comment:
Revision 2 as of 2006-11-15 16:01:47
Size: 2942
Editor: lfrq80
Comment:
Deletions are marked like this. Additions are marked like this.
Line 34: Line 34:
attachment:inhibition1_061115_dwk.png
Line 35: Line 37:

attachment:inhibition2_061115_dwk.png

Use Case Name : Inhibition

For Feature : MIM Editor

Editors: DavidKane

TableOfContents([2])

Summary

A user wants to describe the possibility that one species can inhibit the completion of another reaction.

Step-by-Step User Action

  1. User specifies a species; this is the inhibiting agent
  2. User specifies the reaction that is to be inhibited
  3. User specifies the inhibition relationship
  4. User optionally specifies the evidence for this reaction

Visual Aides

The Kohn notation for this reaction is the following:

attachment:inhibition1_061115_dwk.png

Here is an example of how this symbol would be applied:

attachment:inhibition2_061115_dwk.png

The color in this example is convention, and is not an essential element in the notation.

Requirements for Cytoscape

Could be modeled as a Hyperedge containing node1: C (hyperedge attribute: inhibition), node2: A, node3: B

View: Use case for hyperedge view

Importance

This is one of several reaction modifiers, and it is very common in the maps. There are several other structurally similar relationships.

Other Examples

Comments

The BioPAX representation could be either either a Control (for catalysts) or a Biochemical Reaction.

PageComment2

Molecular_Interaction_Maps/ShowInhibition (last edited 2009-02-12 01:03:33 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux